PMID- 21169404 OWN - NLM STAT- MEDLINE DCOM- 20110526 LR - 20200930 IS - 1522-1539 (Electronic) IS - 0363-6135 (Linking) VI - 300 IP - 3 DP - 2011 Mar TI - Mthfr deficiency induces endothelial progenitor cell senescence via uncoupling of eNOS and downregulation of SIRT1. PG - H745-53 LID - 10.1152/ajpheart.00321.2010 [doi] AB - Hyperhomocysteinemia (HHcy) has been shown to induce endothelial dysfunction in part as a result of enhanced oxidative stress. Function and survival of endothelial progenitor cells (EPCs, defined as sca1(+) c-kit(+) flk-1(+) bone marrow-derived cells), which significantly contribute to neovascularization and endothelial regeneration, depend on controlled production of reactive oxygen species (ROS). Mice heterozygous for the gene deletion of methylenetetrahydrofolate reductase (Mthfr(+/-)) have a 1.5- to 2-fold elevation in plasma homocysteine. This mild HHcy significantly reduced the number of circulating EPCs as well as their differentiation. Mthfr deficiency was also associated with increased ROS production and reduced nitric oxide (NO) generation in Mthfr(+/-) EPCs. Treatment of EPCs with sepiapterin, a precursor of tetrahydrobiopterin (BH(4)), a cofactor of endothelial nitric oxide synthase (eNOS), significantly reduced ROS and improved NO production. mRNA and protein expression of eNOS and the relative amount of eNOS dimer compared with monomer were decreased by Mthfr deficiency. Impaired differentiation of EPCs induced by Mthfr deficiency correlated with increased senescence, decreased telomere length, and reduced expression of SIRT1. Addition of sepiapterin maintained cell senescence and SIRT1 expression at levels comparable to the wild type. Taken together, these results demonstrate that Mthfr deficiency impairs EPC formation and increases EPC senescence by eNOS uncoupling and downregulation of SIRT1. FAU - Lemarie, Catherine A AU - Lemarie CA AD - Lady Davis Institute for Medical Research, Sir Mortimer B. Davis-Jewish General Hospital, McGill University, Montreal, Quebec, Canada. FAU - Shbat, Layla AU - Shbat L FAU - Marchesi, Chiara AU - Marchesi C FAU - Angulo, Orlando J AU - Angulo OJ FAU - Deschenes, Marie-Eve AU - Deschenes ME FAU - Blostein, Mark D AU - Blostein MD FAU - Paradis, Pierre AU - Paradis P FAU - Schiffrin, Ernesto L AU - Schiffrin EL LA - eng GR - 37917/Canadian Institutes of Health Research/Canada GR - 82790/Canadian Institutes of Health Research/Canada PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20101217 PL - United States TA - Am J Physiol Heart Circ Physiol JT - American journal of physiology. Heart and circulatory physiology JID - 100901228 RN - 0 (Pterins) RN - 0 (Reactive Oxygen Species) RN - 31C4KY9ESH (Nitric Oxide) RN - CJQ26KO7HP (sepiapterin) RN - EC 1.14.13.39 (Nitric Oxide Synthase Type III) RN - EC 1.5.1.20 (Methylenetetrahydrofolate Reductase (NADPH2)) RN - EC 3.5.1.- (Sirt1 protein, mouse) RN - EC 3.5.1.- (Sirtuin 1) RN - Methylenetetrahydrofolate reductase deficiency SB - IM MH - Animals MH - Cell Differentiation/genetics MH - Cellular Senescence/*genetics MH - Down-Regulation MH - Endothelial Cells/*enzymology MH - Female MH - Homocystinuria/genetics MH - Hyperhomocysteinemia/drug therapy/enzymology/genetics MH - Methylenetetrahydrofolate Reductase (NADPH2)/deficiency/genetics MH - Mice MH - Muscle Spasticity/genetics MH - Nitric Oxide/metabolism MH - Nitric Oxide Synthase Type III/*metabolism MH - Oxidative Stress/drug effects/genetics MH - Psychotic Disorders/genetics MH - Pterins/pharmacology MH - Reactive Oxygen Species MH - Sirtuin 1/*metabolism MH - Stem Cells/*enzymology MH - Telomere/metabolism EDAT- 2010/12/21 06:00 MHDA- 2011/05/27 06:00 CRDT- 2010/12/21 06:00 PHST- 2010/12/21 06:00 [entrez] PHST- 2010/12/21 06:00 [pubmed] PHST- 2011/05/27 06:00 [medline] AID - ajpheart.00321.2010 [pii] AID - 10.1152/ajpheart.00321.2010 [doi] PST - ppublish SO - Am J Physiol Heart Circ Physiol. 2011 Mar;300(3):H745-53. doi: 10.1152/ajpheart.00321.2010. Epub 2010 Dec 17.